Cargando…
An optimized live bacterial delivery vehicle safely and efficaciously delivers bacterially transcribed therapeutic nucleic acids
There is an unmet need for delivery platforms that realize the full potential of next‐generation nucleic acid therapeutics. The in vivo usefulness of current delivery systems is limited by numerous weaknesses, including poor targeting specificity, inefficient access to target cell cytoplasm, immune...
Autores principales: | Mora, Darcy S. O., Cox, Madeline, Magunda, Forgivemore, Williams, Ashley B., Linke, Lyndsey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9978928/ https://www.ncbi.nlm.nih.gov/pubmed/36874611 http://dx.doi.org/10.1002/elsc.202200037 |
Ejemplares similares
-
Deploying Elemental Iodine in a Vapor Form to Disinfect Water and to Clear Biofilms
por: Hove, Petronella R., et al.
Publicado: (2020) -
Bacterial Outer Membrane Vesicles as Antibiotic Delivery Vehicles
por: Collins, Shannon M., et al.
Publicado: (2021) -
HDL as a drug and nucleic acid delivery vehicle
por: Lacko, Andras G., et al.
Publicado: (2015) -
The Pathogen-Occupied Vacuoles of Anaplasma phagocytophilum and Anaplasma marginale Interact with the Endoplasmic Reticulum
por: Truchan, Hilary K., et al.
Publicado: (2016) -
Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells
por: Prakash, Satya, et al.
Publicado: (2008)